Pharmacovigilance Clinician
Hippocratic AIFull Time
Expert & Leadership (9+ years)
Jersey City, New Jersey, United States
Key technologies and capabilities for this role
Common questions about this position
The role requires a minimum of 3 days a week of onsite presence (or more as business needs require) in the New Jersey office to ensure effective management, operational excellence, and collaboration.
Key skills include exceptional leadership and team management, deep understanding of pharmacovigilance regulations and processes, strong organizational and communication skills, meticulous attention to detail, analytical abilities, and proficiency in pharmacovigilance tools and software.
The environment is dynamic and collaborative, with a focus on strategic leadership, cross-functional team collaboration, and supporting significant team growth.
A strong candidate is an experienced pharmacovigilance leader skilled in overseeing safety reporting, ICSR management, signal detection, and quality assurance, with the ability to manage teams, vendors, and ensure regulatory compliance.
This information is not specified in the job description.
Biotech startup developing innovative medicines
Eikon Therapeutics focuses on discovering and developing new medicines in the pharmaceutical industry. The company employs advanced technologies to study biological systems, aiming to identify new drug targets by examining the dynamic aspects of biology rather than just static chemical processes. Their team consists of diverse professionals, including data scientists, chemists, and engineers, which allows them to combine science and engineering to create new therapies that aim to improve and extend life. A key feature of Eikon's approach is their proprietary single-molecule tracking (SMT) platform, which enables rapid visualization of protein movements in living cells. This technology, along with artificial intelligence and automation, allows for precise inventorying of molecular interactions. Eikon Therapeutics targets patients with serious diseases who need effective treatments, generating revenue through the development and commercialization of their therapies.